Hillstar Bio (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 25, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $67,000,000
Company Info
- Founders
- Robert Mabry, Ph.D.
- Company Description
- Hillstar Bio is developing precision immunotherapies to treat autoimmune diseases.
- Market
- Autoimmune Disease Treatment
- Location
- Boston, MA, USA
- Coinvestors
- DROIA Ventures, Frazier Life Sciences, Hummingbird Bioscience, LifeArc, Novo Holdings